Freestone Capital Holdings’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.76M Buy
+6,704
New +$1.77M 0.05% 202
2022
Q2
– Sell
-2,216
Closed -$527K – 464
2022
Q1
$527K Buy
2,216
+1,083
+96% +$254K 0.02% 339
2021
Q4
$259K Buy
+1,133
New +$249K 0.01% 431
2021
Q1
– Sell
-17
Closed -$3.1K – 520
2020
Q4
$3.1K Sell
17
-75
-82% -$12.8K ﹤0.01% 1076
2020
Q3
$15.4K Buy
+92
New +$15.5K ﹤0.01% 682
2018
Q4
– Sell
-1,541
Closed -$262K – 416
2018
Q3
$262K Buy
+1,541
New +$259K ﹤0.01% 349

Other funds holding CME

Freestone Capital Holdings's CME Position: Q3 2026 in Review

Freestone Capital Holdings opened a new position in CME Group (CME) in Q3 2026: 6,704 shares worth $1.76M. The stake represents 0.05% of the portfolio and ranks #202 among its holdings. This is a return to the name: Freestone Capital Holdings previously reported a position in CME as recently as Q1 2022.

Freestone Capital Holdings first reported a position in CME in Q3 2018 and has held it in 6 quarters since. 1,099 funds tracked by Wall St. Rank hold CME as of Q3 2026.

  • Freestone Capital Holdings held 6,704 shares of CME Group worth $1.76M as of Q3 2026.
  • CME Group was a new Freestone Capital Holdings position in Q3 2026.
  • CME Group made up 0.05% of Freestone Capital Holdings's portfolio in Q3 2026, its #202 holding.
  • Freestone Capital Holdings first reported a position in CME Group in Q3 2018 and has held it in 6 quarters since.
  • 1,099 funds tracked by Wall St. Rank held CME Group as of Q3 2026.

Based on Freestone Capital Holdings's 13F filing for Q3 2026, filed 9 Nov 2026.